observing the intravenous drugs ketamine, dexmeditomidine and combination of ketamine of dexmeditomidine in the mitigation of agitation following general anaesthesia in patients undergoing nasal surgeries
Phase 4
- Conditions
- Health Condition 1: J30-J39- Other diseases of upper respiratory tract
- Registration Number
- CTRI/2023/07/055886
- Lead Sponsor
- John Mammen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of either sex scheduled for elective nasal surgeries under general anaesthesia
-American society of Anesthesiologists physical status I,II
Exclusion Criteria
Patients with altered mental status
Patients on psychoactive/analgesics/ Beta agonist drugs
Pregnant women
Patient with known allergy or hypersensitivity to the drugs used in the study
Patients with anticipated difficult airway
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method